SWOG S0221: A Phase III Trial Comparing Chemotherapy Schedules in High-Risk Early-Stage Breast Cancer

PURPOSE: To determine the optimal dose and schedule of anthracycline and taxane administration as adjuvant therapy for early-stage breast cancer. PATIENTS AND METHODS: A 2 × 2 factorial design was used to test two hypotheses: (1) that a novel continuous schedule of doxorubicin-cyclophosphamide was s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Oncol
Autors principals: Budd, George T., Barlow, William E., Moore, Halle C.F., Hobday, Timothy J., Stewart, James A., Isaacs, Claudine, Salim, Muhammad, Cho, Jonathan K., Rinn, Kristine J., Albain, Kathy S., Chew, Helen K., Burton, Gary V., Moore, Timothy D., Srkalovic, Gordan, McGregor, Bradley A., Flaherty, Lawrence E., Livingston, Robert B., Lew, Danika L., Gralow, Julie R., Hortobagyi, Gabriel N.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2015
Matèries:
ORIGINAL REPORTS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4268253/
https://ncbi.nlm.nih.gov/pubmed/25422488
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.56.3296
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars